Finally, regarding serum LRG-1, the validation work of Tintor et al. [24] also supports the potential use of serum LRG-1 as a molecule for diagnosing PAA, along with our results and the previously published systematic review and meta-analysis [13]. Here, LRG1 is linked to pulmonary artery-aorta diameter ratio measurement.